Protagonist Therapeutics Price Target Increased to $114.50, Up 11.65% from Prior Estimate

Protagonist Therapeutics' average one-year price target has been revised to $114.50, an increase of 11.65% from the prior estimate of $102.55. The price target is an average of many targets provided by analysts, ranging from $97.97 to $131.25. The put/call ratio of PTGX is 0.18, indicating a bullish outlook.